A Sensitive Quantification of Agmatine Using a Hybrid Electrode Based on Zinc oxide Nanoparticles
Abstract
An electrochemical sensor was prepared by modifiying a hybrid of multi-walled carbon nanotubes (MWCNTs) and zinc oxide nanoparticles (ZnONPs) to a glassy carbon (GC) electrode surface to accurately determine agmatine. The ZnONPs+MWCNTs/GC electrode surface was characterized using scanning electron microscopy and energy dispersive X-ray. Agmatine did not exhibit any peak on the GC electrode surface but exhibited a large oxidation peak at 637.9 mV on the MWCNT/GC electrode surface. Furthermore, it was observed that the electrochemical behavior of agmatine was greatly improved on the MWCNT+ZnONPs/GC electrode surface and that this surface exhibited a well-defined higher current peak at 581.9 mV. The electrochemical responses of agmatine on the MWCNT+ZnONPs/GC electrode surface were performed using square wave voltammetry. A linear plot was obtained for the current responses of agmatine against concentrations in the range of 0.1 µM–5.2 µM yielding a detection limit of 4.13×10−6 M (based on 3Sb/m). The accurate quantification of agmatine makes the ZnONPs+MWCNTs/GC electrode system of great interest for the treatment of schizophrenia.
Keywords
References
- 1. Singh T, Bagga N, Kaur A, Kaur N, Gawande DY, Goel RK. Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals. Biomedicine & Pharmacotherapy. 2017;92:720-5.
- 2. Freitas AE, Neis VB, Rodrigues ALS. Agmatine, a potential novel therapeutic strategy for depression. European Neuropsychopharmacology. 2016;26(12):1885-99.
- 3. Gilad GM, Salame K, Rabey JM, Gilad VH. Agmatine treatment is neuroprotective in rodent brain injury models. Life sciences. 1995;58(2):PL41-PL6.
- 4. Feng Y, LeBlanc MH, Regunathan S. Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects. Neuroscience letters. 2005;390(3):129-33.
- 5. Reis DJ, Regunathan S. Is agmatine a novel neurotransmitter in brain? Trends in pharmacological sciences. 2000;21(5):187-93.
- 6. Benítez J, García D, Romero N, González A, Martínez-Oyanedel J, Figueroa M, et al. Metabolic strategies for the degradation of the neuromodulator agmatine in mammals. Metabolism-Clinical and Experimental. 2018;81:35-44.
- 7. Bahremand T, Payandemehr P, Riazi K, Noorian AR, Payandemehr B, Sharifzadeh M, et al. Modulation of the anticonvulsant effect of swim stress by agmatine. Epilepsy & Behavior. 2018;78:142-8.
- 8. Gawali NB, Bulani VD, Chowdhury AA, Deshpande PS, Nagmoti DM, Juvekar AR. Agmatine ameliorates lipopolysaccharide induced depressive-like behaviour in mice by targeting the underlying inflammatory and oxido-nitrosative mediators. Pharmacology Biochemistry and Behavior. 2016;149:1-8.
Details
Primary Language
English
Subjects
Chemical Engineering
Journal Section
Research Article
Authors
Hilal İncebay
*
Türkiye
Publication Date
September 1, 2018
Submission Date
March 5, 2018
Acceptance Date
October 17, 2018
Published in Issue
Year 2018 Volume: 5 Number: 3
